The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes.

ASIAIR > College of Computer Science > Department of Biomedical informatics > Journal Article > Item 310904400/112678

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/112678

Title:	The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes.
Authors:	Li, Shang-Yi;Li, Shang-Yi;Ch, Hsin-Hung;Chen, Hsin-Hung;Lin, Cheng-Li;Lin, Cheng-Li;Yeh, Su-Yin;Yeh, Su-Yin;高嘉鴻;Kao, Chia-Hung
Contributors:	生物資訊與醫學工程學系
Date:	2019-09
Issue Date:	2020-08-19 06:40:15 (UTC+0)
Publisher:	亞洲大學
Abstract:	Purpose To evaluate the long-term efficacy of hydrophilic and lipophilic statin therapy for cardiovascular outcomes in Asian diabetic patients. Method Newly diagnosed cases of type 2 diabetes during the period from January 2000 to December 2011 were divided into 2 cohorts on the basis of their statin use, namely hydrophilic statin and lipophilic statin. We used Cox proportional hazard regression models to analyze the risks of cardiovascular outcomes. Result In this study, 12 896 patients used statin, including 4259 patients using hydrophilic statin and 8637 patients using lipophilic statin. With 12-year follow-up, higher incidence rate of coronary artery disease and stroke was noted in the lipophilic statin use instead of hydrophilic statin use. Conclusion According to our long-term cohort study, hydrophilic statin use may be a better choice than lipophilic statin to reduce cardiovascular events in Asian diabetic patients.
Relation:	Dose-Response
Appears in Collections:	[Department of Biomedical informatics ] Journal Article

Files in This Item:

File	Description	Size	Format
The_Different_Cardiovascular_Outcomes_Between_Long.pdf		422Kb	Adobe PDF	81	View/Open

View Licence